Ruane Medical and Liver Health Institute

Ruane Medical and Liver Health Institute appears to be a private, community-based healthcare and clinical research organization in Los Angeles focused on liver disease and infectious disease care. The organization has been described as specializing in treatment and clinical research for hepatitis C, hepatitis B, HIV, HIV prevention (PrEP), and steatohepatitis/NASH, while also offering patient-facing medical services and liver assessment capabilities such as FibroScan. Its current public-facing research brand is Ruane Clinical Research, which states it has conducted numerous industry-sponsored clinical trials since 2006. Based on the available evidence, this is not a drug-developing biotech company with a proprietary pipeline, but rather a care delivery and trial-site organization supporting biopharma-sponsored studies and patient management.